CIGARETTE-SMOKING AND PLATELET-VESSEL WALL INTERACTIONS

被引:12
作者
LASSILA, R
LAUSTIOLA, KE
机构
[1] Wihuri Research Institute, SF-00140 Helsinki
来源
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS | 1992年 / 46卷 / 02期
关键词
D O I
10.1016/0952-3278(92)90212-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
[No abstract available]
引用
收藏
页码:81 / 86
页数:6
相关论文
共 51 条
[1]
THE EFFECT OF CIGARETTE-SMOKE, NICOTINE, AND CARBON-MONOXIDE ON THE PERMEABILITY OF THE ARTERIAL-WALL [J].
ALLEN, DR ;
BROWSE, NL ;
RUTT, DL ;
BUTLER, L ;
FLETCHER, C .
JOURNAL OF VASCULAR SURGERY, 1988, 7 (01) :139-152
[2]
INTIMAL ULTRASTRUCTURE OF HUMAN UMBILICAL ARTERIES - OBSERVATIONS ON ARTERIES FROM NEWBORN CHILDREN OF SMOKING AND NONSMOKING MOTHERS [J].
ASMUSSEN, I ;
KJELDSEN, K .
CIRCULATION RESEARCH, 1975, 36 (05) :579-589
[3]
CIGARETTE-SMOKING AND CORONARY-ARTERY DISEASE - MACROSCOPIC AND MICROSCOPIC STUDY [J].
AUERBACH, O ;
CARTER, HW ;
GARFINKEL, L ;
HAMMOND, EC .
CHEST, 1976, 70 (06) :697-705
[4]
CIGARETTE-SMOKING - PROFILES OF THROMBOXANE-DERIVED AND PROSTACYCLIN-DERIVED PRODUCTS IN HUMAN-URINE [J].
BARROW, SE ;
WARD, PS ;
SLEIGHTHOLM, MA ;
RITTER, JM ;
DOLLERY, CT .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 993 (01) :121-127
[5]
FACTORS CONTROLLING THROMBUS FORMATION ON ARTERIAL LESIONS [J].
BAUMGARTNER, HR ;
SAKARIASSEN, KS .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 454 :162-177
[6]
BYLOCK A, 1979, ACTA PATH MICRO IM A, V87, P201
[7]
CARO CG, 1990, TOBACCO SMOKING ATHE, P273
[8]
FIBRINOGEN AS A MAJOR RISK FACTOR IN CARDIOVASCULAR-DISEASE [J].
COOK, NS ;
UBBEN, D .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (11) :444-451
[9]
NOREPINEPHRINE AND EPINEPHRINE RELEASE AND ADRENERGIC MEDIATION OF SMOKING-ASSOCIATED HEMODYNAMIC AND METABOLIC EVENTS [J].
CRYER, PE ;
HAYMOND, MW ;
SANTIAGO, JV ;
SHAH, SD .
NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (11) :573-577
[10]
EFFECTS OF TOBACCO AND NON-TOBACCO CIGARETTE-SMOKING ON ENDOTHELIUM AND PLATELETS [J].
DAVIS, JW ;
SHELTON, L ;
EIGENBERG, DA ;
HIGNITE, CE ;
WATANABE, IS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (05) :529-533